| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |